Ligand Pushes Chancery To Squelch $4B Formula-Botch Suit
With billions in the balance, Ligand Pharmaceuticals Inc. urged the Chancery Court Monday to toss a suit over a bungled formula description in an indenture for $250 million in notes, in...To view the full article, register now.
Already a subscriber? Click here to view full article